These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15707727)

  • 21. Studies of piroxicam absorption by oral mucosa.
    Diez-Ortego I; Cruz M; Largo R; Navarro A; Palacios I; Solans A; Sanchez-Pernaute O; Egido J; Herrero-Beaumont G
    Arzneimittelforschung; 2002; 52(5):385-7. PubMed ID: 12087924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved solubility and dissolution rate of piroxicam using gelucire 44/14 and labrasol.
    Karataş A; Yüksel N; Baykara T
    Farmaco; 2005 Sep; 60(9):777-82. PubMed ID: 16084514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
    Zahedi P; Lee PI
    Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transdermal drug delivery using microemulsion and aqueous systems: influence of skin storage conditions on the in vitro permeability of diclofenac from aqueous vehicle systems.
    Sintov AC; Botner S
    Int J Pharm; 2006 Mar; 311(1-2):55-62. PubMed ID: 16431047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of formulated tenoxicam transdermal delivery systems.
    Kim T; Kang E; Chun I; Gwak H
    J Pharm Pharmacol; 2008 Jan; 60(1):135-8. PubMed ID: 18088513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies with ketamine and alfentanil following Freund's complete adjuvant-induced inflammation in rats.
    Edwards SR; Mather LE; Smith MT
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):414-20. PubMed ID: 17439409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved bioavailability of aceclofenac from spherical agglomerates: development, in vitro and preclinical studies.
    Muatlik S; Usha AN; Reddy MS; Ranjith AK; Pandey S
    Pak J Pharm Sci; 2007 Jul; 20(3):218-26. PubMed ID: 17545107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium.
    Manosroi A; Jantrawut P; Manosroi J
    Int J Pharm; 2008 Aug; 360(1-2):156-63. PubMed ID: 18539416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melt sonocrystallized piroxicam for oral delivery: particle characterization, solid state analysis, and pharmacokinetics.
    Gupta PS; Sharma V; Pathak K
    Expert Opin Drug Deliv; 2013 Jan; 10(1):17-32. PubMed ID: 23102052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; Remon JP; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2007 Nov; 67(3):715-24. PubMed ID: 17537625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physicochemical characteristics and oral bioavailability of andrographolide complexed with hydroxypropyl-beta-cyclodextrin.
    Ren K; Zhang Z; Li Y; Liu J; Zhao D; Zhao Y; Gong T
    Pharmazie; 2009 Aug; 64(8):515-20. PubMed ID: 19746840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo evaluation of drug release from semisolid dosage forms.
    Petró E; Balogh A; Blazsó G; Erös I; Csóka I
    Pharmazie; 2011 Dec; 66(12):936-41. PubMed ID: 22312698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclodextrin complexes of valdecoxib: properties and anti-inflammatory activity in rat.
    Rajendrakumar K; Madhusudan S; Pralhad T
    Eur J Pharm Biopharm; 2005 May; 60(1):39-46. PubMed ID: 15848054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of allodynia in patients with complex regional pain syndrome: A double-blind placebo-controlled trial of topical ketamine.
    Finch PM; Knudsen L; Drummond PD
    Pain; 2009 Nov; 146(1-2):18-25. PubMed ID: 19703730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Release study of diclofenac from new carbomer gels.
    Bregni C; Chiappetta D; Faiden N; Carlucci A; García R; Pasquali R
    Pak J Pharm Sci; 2008 Jan; 21(1):12-6. PubMed ID: 18166512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel formulation of solid lipid microparticles of curcumin for anti-angiogenic and anti-inflammatory activity for optimization of therapy of inflammatory bowel disease.
    Yadav VR; Suresh S; Devi K; Yadav S
    J Pharm Pharmacol; 2009 Mar; 61(3):311-21. PubMed ID: 19222903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of surfactants of Rofam type on properties of piroxicam tablets.
    Szulc-Musioł B; Jankowski A
    Acta Pol Pharm; 2009; 66(2):195-200. PubMed ID: 19719055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of matrix controlled transdermal delivery systems of pentazocine: In vitro/in vivo performance.
    Prasad Verma PR; Chandak AR
    Acta Pharm; 2009 Jun; 59(2):171-86. PubMed ID: 19564142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib.
    Baboota S; Shakeel F; Ahuja A; Ali J; Shafiq S
    Acta Pharm; 2007 Sep; 57(3):315-32. PubMed ID: 17878111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer.
    Shaikh J; Ankola DD; Beniwal V; Singh D; Kumar MN
    Eur J Pharm Sci; 2009 Jun; 37(3-4):223-30. PubMed ID: 19491009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.